Anti-DLL4 antibodies and methods using same

Details for Australian Patent Application No. 2007319672 (hide)

Owner GENENTECH, INC.

Inventors Yan, Minhong; Wu, Yan

Agent Griffith Hack

Pub. Number AU-B-2007319672

PCT Pub. Number WO2008/060705

Priority 60/866,772 21.11.06 US; 60/866,767 21.11.06 US; 60/811,357 06.06.06 US; 60/811,349 06.06.06 US

Filing date 6 June 2007

Wipo publication date 22 May 2008

Acceptance publication date 30 June 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/060705 Priority application(s): WO2008/060705

30 June 2011 Application Accepted

  Published as AU-B-2007319672

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319674-Method and apparatus for minimizing the effect of baseline depression in ionizing radiation measuring equipment

2007319669-Replikin peptides and uses thereof